Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2012 Jun;76(6):911–918. doi: 10.1111/j.1365-2265.2011.04328.x

Table 3.

Odds of Prevalent MetS at Baseline by Thyroid Function Category

Thyroid Function Category Participants with MetS at Baseline, n (%) OR (95% CI)
Age, Sex, & Race Adjusted Multivariable Adjusted**
Subclinical Hyperthyroid 16/50 (32) 0.9 (0.5–1.7) 0.8 (0.4–1.6)
Euthyroid 561/1779 (32) Referent Referent
Mild Subclinical Hypothyroid* 80/234 (34) 1.0 (0.8–1.4) 1.0 (0.7–1.5)
Marked Subclinical Hypothyroid* 18/34 (53) 2.2 (1.1–4.4) 2.3 (1.0–5.0)
Overt Hypothyroid 8/21 (38) 1.1 (0.5–2.8) 1.0 (0.4–2.6)
*

Mild Subclinical Hypo = TSH 4.5–9.9 mIU/mL, Marked Subclinical Hypo = TSH 10–20 mIU/mL

**

Adjusted for age, sex, race, smoking status, BMI, and HOMA-IR